Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Edesa Biotech, Inc.

NASDAQ: EDSA · Life Sciences · 4 alerts · CIK 1540159

Share price
$1.89Close, Nov 16
Market cap
$18.2M
Shares outstanding
9.64MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Edesa Biotech, Inc. filings on SEC EDGAR ↗

6:05 AM ET 8-K
Licensing Deal

Edesa Biotech Licensing Deal with Kyorin Pharmaceutical Co., Ltd. Worth $146M

Edesa Biotech granted Kyorin Pharmaceutical an exclusive license to develop and commercialize its anti-TLR4 monoclonal antibody, paridiprubart (EB05), for the treatment of ARDS in Japan. Edesa receives a $12 million upfront payment and is eligible for up to $134 million in development, regulatory, and sales milestones, plus tiered double-digit royalties. Kyorin will fund all development and commercialization activities in Japan while Edesa retains rights in all other territories.

Value
$146M
Counterparty
Kyorin Pharmaceutical Co., Ltd.
Term
15 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.